Shokrollah Elahi

5.2k total citations · 1 hit paper
100 papers, 3.6k citations indexed

About

Shokrollah Elahi is a scholar working on Immunology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Shokrollah Elahi has authored 100 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Immunology, 21 papers in Infectious Diseases and 16 papers in Epidemiology. Recurrent topics in Shokrollah Elahi's work include Immune Cell Function and Interaction (32 papers), Galectins and Cancer Biology (15 papers) and Reproductive System and Pregnancy (12 papers). Shokrollah Elahi is often cited by papers focused on Immune Cell Function and Interaction (32 papers), Galectins and Cancer Biology (15 papers) and Reproductive System and Pregnancy (12 papers). Shokrollah Elahi collaborates with scholars based in Canada, United States and Australia. Shokrollah Elahi's co-authors include Shima Shahbaz, Helen Horton, Isobel Okoye, Volker Gerdts, Petya Koleva, Najmeh Bozorgmehr, Robert Clancy, Lai Xu, Garett Dunsmore and Shahzma Merani and has published in prestigious journals such as Nature, Nature Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Shokrollah Elahi

97 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metabolomic and immune alterations in long COVID patients with chronic fatigue syndrome

2024 42 citations Suguru Saito, Shima Shahbaz et al. Frontiers in Immunology profile →

Peers

Countries citing papers authored by Shokrollah Elahi

Since Specialization

Citations

This map shows the geographic impact of Shokrollah Elahi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shokrollah Elahi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shokrollah Elahi more than expected).

Fields of papers citing papers by Shokrollah Elahi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shokrollah Elahi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shokrollah Elahi. The network helps show where Shokrollah Elahi may publish in the future.

Co-authorship network of co-authors of Shokrollah Elahi

This figure shows the co-authorship network connecting the top 25 collaborators of Shokrollah Elahi. A scholar is included among the top collaborators of Shokrollah Elahi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shokrollah Elahi. Shokrollah Elahi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Integrated immune, hormonal, and transcriptomic profiling reveals sex-specific dysregulation in long COVID patients with ME/CFS 2025 ·Cell Reports Medicine ·Shima Shahbaz, Mohammed Osman, (unknown), Andrew L. Mason, Rhonda J. Rosychuk, Jan Willem Cohen Tervaert, Shokrollah Elahi	1
2	Polyfunctional CD 8 ⁺ CD 226 ⁺ RUNX 2 ^hi effector T cells are diminished in advanced stages of chronic lymphocytic leukemia 2025 ·Molecular Oncology ·(unknown), Shima Shahbaz, Anthea Peters, Spencer B. Gibson, Shokrollah Elahi	1
3	Clinical and mechanistic advancements in aspirin exacerbated respiratory disease 2025 ·Journal of Allergy and Clinical Immunology ·Shokrollah Elahi, Anju T. Peters, Atsushi Kato, Whitney W. Stevens	0
4	Exploring the role of galectin-9 and artemin as biomarkers in long COVID with chronic fatigue syndrome: links to inflammation and cognitive function 2024 ·Frontiers in Immunology ·Shokrollah Elahi, (unknown), Mohammed Osman, Shima Shahbaz	6
5	Upregulation of olfactory receptors and neuronal-associated genes highlights complex immune and neuronal dysregulation in Long COVID patients 2024 ·Brain Behavior and Immunity ·Shima Shahbaz, (unknown), (unknown), Desiree Redmond, (unknown), Mohammed Osman, Shokrollah Elahi	5
6	DNA methylation changes underlie the long-term association between periodontitis and atherosclerotic cardiovascular disease 2023 ·Frontiers in Cardiovascular Medicine ·Mohamed A. Omar, Maria Alexiou, (unknown), (unknown), (unknown), (unknown), Shokrollah Elahi, Maria Febbraio	7
7	Immunological responses in SARS-CoV-2 and HIV co-infection versus SARS-CoV-2 mono-infection: case report of the interplay between SARS-CoV-2 and HIV 2023 ·Allergy Asthma and Clinical Immunology ·Shima Shahbaz, Wendy Sligl, Mohammed Osman, Shokrollah Elahi	4
8	Galectin-9 promotes natural killer cells activity via interaction with CD44 2023 ·Frontiers in Immunology ·(unknown), (unknown), Shokrollah Elahi	25
9	Depletion of polyfunctional CD26highCD8+ T cells repertoire in chronic lymphocytic leukemia 2023 ·Experimental Hematology and Oncology ·Najmeh Bozorgmehr, (unknown), Anthea Peters, Shokrollah Elahi	22
10	Transcriptomic profiling of peripheral blood cells in HPV ‐associated carcinoma patients receiving combined valproic acid and avelumab 2023 ·Molecular Oncology ·Najmeh Bozorgmehr, (unknown), (unknown), John Walker, Shokrollah Elahi	4
11	CD71⁺ erythroid cells suppress T-cell effector functions and predict immunotherapy outcomes in patients with virus-associated solid tumors 2023 ·Journal for ImmunoTherapy of Cancer ·Najmeh Bozorgmehr, Isobel Okoye, (unknown), (unknown), Petya Koleva, John Walker, Shokrollah Elahi	16
12	Differential effects of age, sex and dexamethasone therapy on ACE2/TMPRSS2 expression and susceptibility to SARS-CoV-2 infection 2022 ·Frontiers in Immunology ·Shima Shahbaz, (unknown), Suguru Saito, Mohammed Osman, Wendy Sligl, Shokrollah Elahi	7
13	The Quality of SARS-CoV-2–Specific T Cell Functions Differs in Patients with Mild/Moderate versus Severe Disease, and T Cells Expressing Coinhibitory Receptors Are Highly Activated 2021 ·The Journal of Immunology ·Shima Shahbaz, Lai Xu, Wendy Sligl, Mohammed Osman, Najmeh Bozorgmehr, (unknown), Desiree Redmond, (unknown), John Walker, Shokrollah Elahi	44
14	Neutrophils promote T-cell activation through the regulated release of CD44-bound Galectin-9 from the cell surface during HIV infection 2021 ·PLoS Biology ·Garett Dunsmore, (unknown), Shima Shahbaz, Deanna M. Santer, Juan Jovel, Paige Lacy, Stan Houston, Shokrollah Elahi	29
15	Differential Signature of the Microbiome and Neutrophils in the Oral Cavity of HIV-Infected Individuals 2021 ·Frontiers in Immunology ·(unknown), (unknown), Juan Jovel, Conar O’Neil, (unknown), (unknown), Shokrollah Elahi	17
16	Tackling Immune Targets for Breast Cancer: Beyond PD-1/PD-L1 Axis 2021 ·Frontiers in Oncology ·Yasser Tabana, Isobel Okoye, Arno G. Siraki, Shokrollah Elahi, Khaled Barakat	14
17	Neglected Cells: Immunomodulatory Roles of CD71+ Erythroid Cells 2019 ·Trends in Immunology ·Shokrollah Elahi	48
18	CD71+ erythroid suppressor cells impair adaptive immunity against Bordetella pertussis 2017 ·Scientific Reports ·Afshin Namdar, Petya Koleva, Shima Shahbaz, Stacy Strom, Volker Gerdts, Shokrollah Elahi	50
19	Atorvastatin restricts HIV replication in CD4+ T cells by upregulation of p21 2015 ·AIDS ·Shokrollah Elahi, Robert H. Weiss, Shahzma Merani	57
20	Development of surrogate markers for oral immunisation against Candida albicans 2003 ·Vaccine ·Shokrollah Elahi	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact